Scimplify Secures $40 Million for Specialty Chemicals

Scimplify is revolutionising the specialty chemicals sector with its impressive $40 million raised in Series B funding. This round was co-led by Accel and Bertelsmann India Investments, with additional investment from UMI and returning investors like Omnivore and 3one4 Capital. This latest funding round brings Scimplify’s overall capital accumulation to $54 million, following earlier seed and Series A rounds.

The new capital will facilitate Scimplify’s expansion into international markets beyond the current 16 countries it serves, whilst also augmenting its footprint in vital industries including life sciences, crop sciences, and industrial chemicals, as detailed in a recent press release.

Overcoming Challenges in Manufacturing

Manufacturers frequently face hurdles in sourcing raw materials, complying with regulations, and ramping up production to satisfy worldwide demand. Scimplify is tackling these obstacles by providing a complete manufacturing ecosystem, which merges in-house scientific expertise with a network featuring over 200 specialised manufacturing plants situated in economically efficient areas throughout India.

The Scimplify Model

Founded by Salil Srivastava and Sachin Santhosh, Scimplify operates as a B2B fulfilment platform that encompasses the entire product life cycle, including contract research and commercial chemical manufacturing, catering to sectors such as pharmaceuticals, personal care, and agrochemicals. The company’s plug-and-play model allows international buyers to benefit from India’s cost-effective production capabilities without the complications associated with establishing dedicated manufacturing plants.

Strategic Partnerships for Growth

As global supply chains experience swift transformations, customers are on the lookout for dependable partners that can offer enterprise-level R&D and all-encompassing solutions for their specialty chemical manufacturing requirements. Over the past year and a half, Scimplify has gained substantial traction, and with the addition of Accel to their partnership, the company is committed to developing a global R&D-driven manufacturing entity that introduces a contemporary approach to meet the demands of modern clients, explained Srivastava.

Key Markets and Competition

Based in Bengaluru, Scimplify serves significant markets such as the US, Europe, and Japan. It finds itself in competition with companies like Mstack, Atomgrid, Covvalent, Distil, and Elchemy. Last year, Mstack, a cross-border specialty chemical manufacturing platform, also secured $40 million in its Series A funding round, led by Lightspeed and Alphawave. Other competitors such as Atomgrid, Distil, and Elchemy also attracted notable funding last year.